Synopsys draws guidance by referring to new Chinese export restrictions

Synops The management for the full fiscal year on Thursday, asked a letter to restrict the sale of products in China from the US trade department. The stock closes 1.6%.

Ad Sinopsy comes a day after Sassence Ghazi A report argued The White House company, as well as opponents said Cadence and SiemensTo stop selling customers in China. Said they want to eliminate the change in the assumption.

“Synopsys currently assess the fact that the letter of BIS is on its work, operational results and financial status and potential impact of the financial situation,” the company said on Thursday.

With the call to the conference with analysts on Wednesday, Ghazi said that the company slowed in China during this period Financial second quarterAbout 10% of 30% of Synops, which ended on April 30, came from customers to $ 1.6 billion in China.

Competition in China is severe. Synopsys said that the Chinese government has laid its own policy, which supports its companies while trying to develop its own companies and develop an independent chip.

“FY was stronger in 2024, as well as in China, but also in China, but also the slowdown of this slowing down, and every quarter was stronger in half,” he said. 2025 Finance Year ends in October.

Last week, the Industry and Security Bureau said the company’s chip design program will need a license to export customers in China Thursday.

“In the letter, BIS determined that these shipments are violated in China or the Chinese ‘use of the military to the Chinese’ ‘use of the existing risk of using the military tip’, ‘” said Cadence.

Follow: Sinopsys stops Q3 and FY 2025 management a day after providing this